Looking at Brenda Griffin today, it's hard to believe that, not long ago, she was nudging 15st on the bathroom scales - and ...

True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to gain weight. The FDA and CDC jointly recommended to pause use of the ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

A 2023 test showing that Novo Nordisk (NYSE: NVO )’s Wegovy weight-loss medication not only helped people lose weight but ...

COMMENT: Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes ...

Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes Charlotte ...

May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Two in three adults over the age of 25 could be obese or overweight by 2050, experts have warned. Access to healthy and ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...